These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 8061763)

  • 1. Improvement of patient convenience in treatment with growth hormone.
    Jørgensen JT
    J Pediatr Endocrinol; 1994; 7(2):175-80. PubMed ID: 8061763
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patient acceptance of Nordiject: a new drug delivery system for growth hormone.
    Jørgensen JT; Mortensen HB; Jørgensen JO
    DICP; 1991 Jun; 25(6):585-8. PubMed ID: 1877265
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Growth hormone therapy with a new delivery system.
    Jørgensen JT; Susgaard S
    Indian J Pediatr; 1991; 58 Suppl 1():43-50. PubMed ID: 1824374
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Automatic needle insertion diminishes pain during growth hormone injection.
    Main KM; Jørgensen JT; Hertel NT; Jensen S; Jakobsen L
    Acta Paediatr; 1995 Mar; 84(3):331-4. PubMed ID: 7780258
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Norditropin SimpleXx: a liquid human growth hormone formulation, a pen system and an auto-insertion device.
    Müller J; Skakkebaek NE; Jacobsen BB; Keller E; Heinrich U; Hartmann K; Hokken-Koelega AC; Delemarre van de Waal HA
    Horm Res; 1999; 51 Suppl 3():109-12. PubMed ID: 10592453
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bacterial contamination of growth hormone solution and injection equipment during use by growth hormone deficient children.
    Zweens MJ; Drayer NM; Dankert J
    J Hosp Infect; 1991 Jun; 18(2):123-30. PubMed ID: 1678757
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genotropin 16 IU KabiVial is more convenient than conventional administration systems for children on growth hormone therapy.
    Danielson K; Neumeyer L; Ritzén M
    Acta Paediatr Scand Suppl; 1990; 370():208-11. PubMed ID: 2260453
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liquid growth hormone: preservatives and buffers.
    Kappelgaard AM; Bojesen A; Skydsgaard K; Sjögren I; Laursen T
    Horm Res; 2004; 62 Suppl 3():98-103. PubMed ID: 15539807
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patient evaluation of a new injection pen for growth hormone treatment in children and adults.
    Sjöblom K; Albertsson-Wikland K; Bengtsson BA; Johannsson G; Thorén M; Degerblad M; Savage MO
    Acta Paediatr Suppl; 1995 Sep; 411():63-5. PubMed ID: 8563072
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Psychological responses to the needle-free Medi-Jector or the multidose Disetronic injection pen in human growth hormone therapy.
    Verrips GH; Hirasing RA; Fekkes M; Vogels T; Verloove-Vanhorick SP; Delemarre-Van de Waal HA
    Acta Paediatr; 1998 Feb; 87(2):154-8. PubMed ID: 9512200
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth hormone delivery devices: current features and potential for enhanced treatment adherence.
    Rohrer TR; Horikawa R; Kappelgaard AM
    Expert Opin Drug Deliv; 2017 Nov; 14(11):1253-1264. PubMed ID: 27718757
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment with growth hormone. What do children know and how do they accept it?
    López Siguero JP; Martínez Aedo MJ; López Moreno MD; Martínez Valverde A
    Horm Res; 1995; 44 Suppl 3():18-25. PubMed ID: 8719436
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessing compliance, acceptance, and tolerability of teriparatide in patients with osteoporosis who fractured while on antiresorptive treatment or were intolerant to previous antiresorptive treatment: an 18-month, multicenter, open-label, prospective study.
    Adachi JD; Hanley DA; Lorraine JK; Yu M
    Clin Ther; 2007 Sep; 29(9):2055-67. PubMed ID: 18035204
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Growth hormone administration by means of an injection pen.
    Jørgensen JO; Møller J; Jensen FS; Jørgensen JT; Christiansen JS
    Pharmacol Toxicol; 1989 Aug; 65(2):96-9. PubMed ID: 2813289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ease of use and acceptability of a new pen device for the administration of growth hormone therapy in pediatric patients: an open-label, uncontrolled usability test.
    Fuchs GS; Mikkelsen S; Knudsen TK; Kappelgaard AM
    Clin Ther; 2009 Dec; 31(12):2906-14. PubMed ID: 20110030
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimum method for administration of biosynthetic human growth hormone: a randomised crossover trial of an Auto Injector and a pen injection system.
    Stanhope R; Albanese A; Moyle L; Hamill G
    Arch Dis Child; 1992 Aug; 67(8):994-7. PubMed ID: 1520018
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A multicenter, randomized, open-label, comparative, two-period crossover trial of preference, efficacy, and safety profiles of a prefilled, disposable pen and conventional vial/syringe for insulin injection in patients with type 1 or 2 diabetes mellitus.
    Korytkowski M; Bell D; Jacobsen C; Suwannasari R;
    Clin Ther; 2003 Nov; 25(11):2836-48. PubMed ID: 14693308
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Growth hormone (GH) deficiency treatment in children: comparison between uses of pen versus bottles/syringes on GH administration].
    Marchisotti FG; Carvalho LR; Berger K; Arnhold IJ; Mendonça BB
    Arq Bras Endocrinol Metabol; 2007 Oct; 51(7):1093-6. PubMed ID: 18157384
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of a pen injector system for growth hormone treatment.
    Gluckman PD; Cutfield WS
    Arch Dis Child; 1991 Jun; 66(6):686-8. PubMed ID: 2053787
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FlexPen: addressing issues of confidence and convenience in insulin delivery.
    Korytkowski M; Niskanen L; Asakura T
    Clin Ther; 2005; 27 Suppl B():S89-100. PubMed ID: 16519040
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.